News

Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore – LIJ has also enrolled patients

The pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness. Progenics said that the new pre-filled syringes

As per the terms of the agreement, Eisai is expected to grant Brain Factory the exclusive rights to develop, commercialise, and sublicense ravuconazole prodrug in Japan as an

The RevitaLens Ocutec multi-purpose disinfecting solution delivers high-quality disinfection and comfort for the user, with the convenience of a single bottle, Abbott said. Abbott Medical Optics senior vice

Rooney has experience in working at management and director levels in the packaging industry within the pharmaceutical and healthcare markets, which will support the Clondalkin’s strategic growth plans

Quidel claims that QuickVue RSV 10 detects RSV antigen directly from nasopharyngeal swab and nasopharyngeal aspirate/wash specimens from symptomatic patients under the age of six. Quidel president and

Astellas is seeking an approval for the indication of the prevention of venous thromboembolism (VTE) in patients at risk, such as those undertaking orthopedic surgical procedures in the

To initiate the production, Zydus Nycomed will manufacture Pantoprazole, Urapidil and Lornoxicam. Further, the company will produce eight additional APIs by 2011. Zydus Nycomed claims that the plant

UMN-0501 is a cell culture based H5N1 avian influenza vaccine, currently under preparation for Phase III clinical trial in Japan. UMN-0502 is a cell culture based seasonal influenza